In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
Search Results for: mmed.ne
On Tuesday September 27th 2022, psychedelics company MindMed (MMED.NE) announced the pricing of a public offering of common shares and warrants. An offering that the market saw as highly…
Mind Medicine (MMED.NE) announced the publication of the first pharmacogenetic data on LSD to help personalize dosing. The study results from a pooled secondary analysis of four Phase I…
Street cred MindMed (MMED.NEO) announced last fall it was applying to be listed on the Nasdaq Exchange. MindMed would be the first Canadian psychedelics company listed on a major…
“The truth is that everyone is bored, and devotes himself to cultivating habits.” – Albert Camus, The Plague E-commerce For decades companies have invested billions trying to understand consumer behavior,…
MindMed (MMED.NE) announced the publication of the first study on MDMA dosing optimisation using personalised medicine. The study was conducted at the University Hospital Basel Liechti Lab, in Basel,…
“Life is too short to be small.” – Tim Ferriss, The 4-Hour Workweek Every psychedelics company starts its investor deck off with a fact about the quickly changing regulatory…
Some positive action on psychedelic stocks in the last few days. As a technical analyst, there are good signs indicating a reversal is occurring. The downtrend is over, and…
Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector…
The world’s first psychedelic ETF, PSYK, is an industry bellwether which indicates the psychedelics space continues to take a drubbing since the ETF launched in January. The fund closed…